Skip to main content

Closed

GH: Guardant Health, Inc. Stock Analysis | finqOS

Healthcare · Medical - Diagnostics & Research

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+31.0% / yr

Operating margin-39.7%

ROIC-29.8%

Financially safe

Strong

Debt / equity-7.49×

Interest coverage825.0×

Current ratio4.03×

Guardant Health, Inc.

GHNASDAQ Global Select·USD·Closed

Guardant Health, Inc.

GHNASDAQ·USD·Closed

$161.99

+6.33%

$161.99

+$9.64 (6.33%)

52W Range

89thpctl

Volume

1.74×avg

Mkt Cap

21.48BUSD

P/E

-46.4TTM

Div Yield

–ann

52W Range

89thpctl

Volume

1.74×avg

Market Cap

21.48BUSD

P/E Ratio

-46.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings